triphosphoric acid has been researched along with Neoplasms in 12 studies
triphosphoric acid: used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative; RN given refers to parent cpd; structure
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This chapter summarizes the anticancer efficacy of FA with an emphasis on the role of apoptosis, and underlying molecular mechanisms involving various signaling pathways in tumor cells." | 2.72 | Ferulic acid-mediated modulation of apoptotic signaling pathways in cancer. ( Bishayee, A; Gupta, A; Loka, M; Pandey, AK; Singh, AK, 2021) |
| "Pathophysiological barriers in "cold" tumors seriously limit the clinical outcomes of chemoimmunotherapy." | 1.91 | "Dominolike" Barriers Elimination with an Intratumoral Adenosine-Triphosphate-Supersensitive Nanogel to Enhance Cancer Chemoimmunotherapy. ( Dong, J; Duan, B; Huang, K; Li, C; Li, J; Sun, M; Yang, R; Zhang, F; Zhi, F; Zhou, Z, 2023) |
| " Therefore, physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models for encapsulated and unencapsulated dFdC were constructed considering the tumor dFdCTP concentration as an index of antitumor activity." | 1.72 | A physiologically based pharmacokinetic and pharmacodynamic model for disposition of FF-10832. ( Ioroi, T; Kato, Y; Kimura, T; Kitahara, H; Masuo, Y; Matsumoto, T; Tanaka, A; Yamakawa, T, 2022) |
| "Clofarabine triphosphate is an intracellular active metabolite of clofarabine." | 1.40 | A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells. ( Chen, X; Lu, Y; Tu, X; Zhang, Y; Zhong, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, T | 1 |
| Masuo, Y | 1 |
| Tanaka, A | 1 |
| Kimura, T | 1 |
| Ioroi, T | 1 |
| Yamakawa, T | 1 |
| Kitahara, H | 1 |
| Kato, Y | 1 |
| Zhang, F | 1 |
| Dong, J | 1 |
| Huang, K | 1 |
| Duan, B | 1 |
| Li, C | 1 |
| Yang, R | 1 |
| Li, J | 1 |
| Zhi, F | 1 |
| Zhou, Z | 1 |
| Sun, M | 1 |
| Gupta, A | 1 |
| Singh, AK | 1 |
| Loka, M | 1 |
| Pandey, AK | 1 |
| Bishayee, A | 1 |
| Puy, JY | 1 |
| Jordheim, LP | 1 |
| Cros-Perrial, E | 1 |
| Dumontet, C | 1 |
| Peyrottes, S | 1 |
| Lefebvre-Tournier, I | 1 |
| Xia, R | 1 |
| Zheng, X | 1 |
| Hu, X | 1 |
| Liu, S | 1 |
| Xie, Z | 1 |
| Tu, X | 1 |
| Lu, Y | 1 |
| Zhong, D | 1 |
| Zhang, Y | 1 |
| Chen, X | 1 |
| Nogueira-Librelotto, DR | 1 |
| Scheeren, LE | 1 |
| Vinardell, MP | 1 |
| Mitjans, M | 1 |
| Rolim, CMB | 1 |
| Li, N | 1 |
| Hu, YL | 1 |
| He, CX | 1 |
| Hu, CJ | 1 |
| Zhou, J | 1 |
| Tang, GP | 1 |
| Gao, JQ | 1 |
| EMMELOT, P | 1 |
| BOS, CJ | 1 |
| BURDON, RH | 1 |
| SMELLIE, RM | 1 |
| MUNCH-PETERSEN, A | 1 |
| GASPARRI, F | 1 |
| BATTAGLIA, GB | 1 |
| PERITI, P | 1 |
1 review available for triphosphoric acid and Neoplasms
| Article | Year |
|---|---|
Ferulic acid-mediated modulation of apoptotic signaling pathways in cancer.
Topics: Animals; Apoptosis; Chitosan; Coumaric Acids; Drug Carriers; Gene Expression Regulation, Neoplastic; | 2021 |
11 other studies available for triphosphoric acid and Neoplasms
| Article | Year |
|---|---|
A physiologically based pharmacokinetic and pharmacodynamic model for disposition of FF-10832.
Topics: Animals; Cytidine Deaminase; Humans; Mice; Neoplasms; Polyphosphates | 2022 |
"Dominolike" Barriers Elimination with an Intratumoral Adenosine-Triphosphate-Supersensitive Nanogel to Enhance Cancer Chemoimmunotherapy.
Topics: Adenosine; Adenosine Triphosphate; Cell Line, Tumor; Humans; Immunotherapy; Nanogels; Neoplasms; Tum | 2023 |
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Antineoplastic Agents; Arabinonucleosides; Cell Line, T | 2017 |
Photothermal-Controlled Generation of Alkyl Radical from Organic Nanoparticles for Tumor Treatment.
Topics: Biocompatible Materials; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Hep G2 Cells; Humans; Lasers | 2019 |
A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Arabinonucleosides; Chromatography, Liquid; Cl | 2014 |
Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cell Proliferation; Cells, Cultured; Chitosan; Doxorubicin; Dr | 2016 |
Preparation, characterisation and anti-tumour activity of Ganoderma lucidum polysaccharide nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; HeLa Cells; Hep G2 Cells; | 2010 |
Studies on isolated tumour mitochondria; phosphate release from adenosine di- and triphosphates.
Topics: Adenosine; Adenosine Triphosphate; Mitochondria; Neoplasms; Nucleotides; Phosphates; Polyphosphates | 1957 |
The incorporation of uridine 5'-triphosphate into ribonucleic acid by enzyme fractions from Ehrlich ascites carcinoma cells.
Topics: Ascites; Biochemical Phenomena; Enzymes; Neoplasms; Nucleosides; Nucleotides; Polyphosphates; RNA; U | 1961 |
Formation in vitro of deoxyadenosine triphosphate from deoxyadenosine in Ehrlich ascites cells.
Topics: Adenine Nucleotides; Ascites; Deoxyadenine Nucleotides; Deoxyadenosines; In Vitro Techniques; Neopla | 1960 |
[HISTOCHEMICAL CHANGES IN THE NUCLEIC ACIDS, 5-NUCLEOTIDASES, ALKALINE PHOSPHATASE AND ADENOSINE TRIPHOSPHORIC ACID IN UTERINE CERVICAL CARCINOMA AFTER TREATMENT WITH TRIETHYLENIMINOBENZOQUINONE].
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Alkaline Phosphatase; Antineoplastic Agents; Car | 1963 |